Ono Pharmaceutical Quick Ratio 2010-2023 | OPHLF

Historical quick ratio values for Ono Pharmaceutical (OPHLF) over the last 10 years.
Ono Pharmaceutical Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2023-09-30 $2.12B $0.70B 3.04
2023-06-30 $2.01B $0.67B 3.01
2022-06-30 $2.07B $0.58B 3.59
2021-06-30 $1.86B $0.74B 2.53
2020-06-30 $1.77B $0.71B 2.49
2019-06-30 $1.34B $0.66B 2.03
2018-06-30 $1.61B $0.61B 2.65
2017-06-30 $1.73B $0.51B 3.39
2016-06-30 $2.00B $0.49B 4.04
2016-03-31 $1.79B $0.47B 3.84
2015-12-31 $0.00B 0.00
2015-09-30 $1.49B $0.30B 4.91
2015-06-30 $1.43B $0.31B 4.54
2015-03-31 $1.43B $0.29B 4.92
2014-12-31 $1.37B $0.29B 4.66
2014-09-30 $1.43B $0.23B 6.26
2014-06-30 $1.61B $0.32B 5.02
2014-03-31 $1.68B $0.27B 6.16
2013-12-31 $1.80B $0.25B 7.13
2013-09-30 $1.96B $0.24B 8.08
2013-06-30 $1.89B $0.28B 6.81
2013-03-31 $2.04B $0.27B 7.42
2012-12-31 $2.12B $0.28B 7.57
2012-09-30 $2.36B $0.32B 7.49
2012-06-30 $2.28B $0.39B 5.83
2012-03-31 $2.24B $0.38B 5.92
2011-12-31 $2.43B $0.34B 7.11
2011-06-30 $0.00B 0.00
2011-03-31 $0.00B 0.00
2010-06-30 $0.00B 0.00
2009-06-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $3.310B
Ono Pharmaceuticals produces, purchases and sells pharmaceuticals and diagnostic reagents focusing primarily on prescription pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $70.026B 28.78
Chugai Pharmaceutical (CHGCY) Japan $53.561B 23.26
Takeda Pharmaceutical (TAK) Japan $41.649B 6.75
Merck (MKGAF) Germany $20.517B 19.36
Astellas Pharma (ALPMY) Japan $17.138B 24.28
Shionogi (SGIOY) Japan $14.066B 12.17
Sandoz Group AG (SDZNY) Switzerland $13.508B 0.00
Neurocrine Biosciences (NBIX) United States $13.189B 54.77
United Therapeutics (UTHR) United States $11.150B 11.94
Catalent (CTLT) United States $10.098B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.652B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.884B 6.98
Ionis Pharmaceuticals (IONS) United States $5.948B 0.00
Revolution Medicines (RVMD) United States $5.901B 0.00
Orion OYJ (ORINY) Finland $5.081B 21.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.422B 0.00
Alpine Immune Sciences (ALPN) United States $4.223B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.994B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.801B 0.00
Indivior (INDV) United States $2.587B 12.03
Evotec AG (EVO) Germany $2.534B 0.00
Summit Therapeutics (SMMT) United States $2.463B 0.00
Corcept Therapeutics (CORT) United States $2.346B 23.85
Dyne Therapeutics (DYN) United States $2.038B 0.00
PTC Therapeutics (PTCT) United States $1.891B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.810B 18.71
Fusion Pharmaceuticals (FUSN) Canada $1.803B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.736B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.735B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.646B 9.75
Taro Pharmaceutical Industries (TARO) Israel $1.586B 27.76
Avadel Pharmaceuticals (AVDL) Ireland $1.574B 0.00
Ardelyx (ARDX) United States $1.499B 0.00
4D Molecular Therapeutics (FDMT) United States $1.268B 0.00
Pacira BioSciences (PCRX) United States $1.214B 12.08
Soleno Therapeutics (SLNO) United States $1.206B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.190B 11.18
Xencor (XNCR) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.137B 7.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.056B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.928B 0.00
Cronos Group (CRON) Canada $0.921B 0.00
Cassava Sciences (SAVA) United States $0.916B 0.00
Ocular Therapeutix (OCUL) United States $0.871B 0.00
USANA Health Sciences (USNA) United States $0.836B 13.17
Enliven Therapeutics (ELVN) United States $0.827B 0.00
ARS Pharmaceuticals (SPRY) United States $0.814B 0.00
Relay Therapeutics (RLAY) United States $0.802B 0.00
Sage Therapeutics (SAGE) United States $0.783B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.696B 0.00
Savara (SVRA) United States $0.662B 0.00
Silence Therapeutics (SLN) United Kingdom $0.659B 0.00
Lyell Immunopharma (LYEL) United States $0.592B 0.00
Siga Technologies (SIGA) United States $0.585B 8.66
Verve Therapeutics (VERV) United States $0.557B 0.00
ProKidney (PROK) United States $0.550B 0.00
OmniAb (OABI) United States $0.538B 0.00
Korro Bio (KRRO) United States $0.536B 0.00
Exscientia (EXAI) United Kingdom $0.527B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.526B 0.00
Altimmune (ALT) United States $0.488B 0.00
KalVista Pharmaceuticals (KALV) United States $0.485B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.447B 0.00
Heron Therapeutics (HRTX) United States $0.407B 0.00
Larimar Therapeutics (LRMR) United States $0.407B 0.00
Tourmaline Bio (TRML) United States $0.402B 0.00
Lexeo Therapeutics (LXEO) United States $0.398B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.384B 0.00
Harrow (HROW) United States $0.384B 0.00
Organogenesis (ORGO) United States $0.377B 71.50
Bioventus (BVS) United States $0.360B 0.00
Esperion Therapeutics (ESPR) United States $0.354B 0.00
Nature's Sunshine Products (NATR) United States $0.352B 19.68
Aquestive Therapeutics (AQST) United States $0.330B 0.00
Lyra Therapeutics (LYRA) United States $0.322B 0.00
Fractyl Health (GUTS) United States $0.315B 0.00
ESSA Pharma (EPIX) Canada $0.297B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.293B 0.00
Akebia Therapeutics (AKBA) United States $0.291B 0.00
Metagenomi (MGX) United States $0.290B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.280B 0.00
Black Diamond Therapeutics (BDTX) United States $0.274B 0.00
Pyxis Oncology (PYXS) United States $0.263B 0.00
Adherex Technologies (FENC) United States $0.259B 0.00
Nanobiotix S.A (NBTX) France $0.259B 0.00
Xeris Biopharma Holdings (XERS) United States $0.247B 0.00
Nektar Therapeutics (NKTR) United States $0.242B 0.00
Acrivon Therapeutics (ACRV) United States $0.239B 0.00
Telomir Pharmaceuticals (TELO) United States $0.235B 0.00
Foghorn Therapeutics (FHTX) United States $0.235B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Avita Medical (RCEL) United States $0.228B 0.00
Conduit Pharmaceuticals (CDT) United States $0.218B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Zevra Therapeutics (ZVRA) United States $0.195B 0.00
Century Therapeutics (IPSC) United States $0.193B 0.00
Profound Medical (PROF) Canada $0.192B 0.00
Prelude Therapeutics (PRLD) United States $0.189B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.184B 0.00
MediWound (MDWD) Israel $0.161B 0.00
Achieve Life Sciences (ACHV) Canada $0.157B 0.00
Incannex Healthcare (IXHL) Australia $0.151B 0.00
CytoDyn (CYDY) United States $0.150B 0.00
Karyopharm Therapeutics (KPTI) United States $0.147B 0.00
VAXART, INC (VXRT) United States $0.146B 0.00
Regulus Therapeutics (RGLS) United States $0.145B 0.00
Elite Pharmaceuticals (ELTP) United States $0.143B 13.35
GlycoMimetics (GLYC) United States $0.139B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.134B 2.83
Relmada Therapeutics (RLMD) United States $0.130B 0.00
Citius Pharmaceuticals (CTXR) United States $0.128B 0.00
Inotiv (NOTV) United States $0.121B 0.00
Eliem Therapeutics (ELYM) United States $0.116B 0.00
FibroGen (FGEN) United States $0.116B 0.00
Cardiol Therapeutics (CRDL) Canada $0.114B 0.00
OptiNose (OPTN) United States $0.105B 0.00
Vivani Medical (VANI) United States $0.099B 0.00
ProPhase Labs (PRPH) United States $0.098B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
AlloVir (ALVR) United States $0.085B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.077B 0.00
Assertio Holdings (ASRT) United States $0.072B 5.80
Journey Medical (DERM) United States $0.071B 0.00
Carisma Therapeutics (CARM) United States $0.071B 0.00
Tempest Therapeutics (TPST) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Mural Oncology (MURA) $0.060B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.059B 0.00
SCYNEXIS (SCYX) United States $0.053B 0.79
BioLineRx (BLRX) Israel $0.051B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.049B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Unicycive Therapeutics (UNCY) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Viracta Therapeutics (VIRX) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
VYNE Therapeutics (VYNE) United States $0.032B 0.00
JanOne (JAN) United States $0.032B 0.00
Nutriband (NTRB) United States $0.032B 0.00
Protara Therapeutics (TARA) United States $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Lipocine (LPCN) United States $0.029B 0.00
NRx Pharmaceuticals (NRXP) United States $0.029B 0.00
DURECT (DRRX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 11.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
CERo Therapeutics Holdings (CERO) United States $0.023B 0.00
Addex Therapeutics (ADXN) Switzerland $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.022B 1.09
Indaptus Therapeutics (INDP) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.019B 0.00
Surrozen (SRZN) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Talphera (TLPH) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.017B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Inhibikase Therapeutics (IKT) United States $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Biomerica (BMRA) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.010B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.19
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 45.81